Know Cancer

or
forgot password
  • cancer clinical trials in ann arbor, MI

  • Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    Saint Joseph Mercy Hospital
    Ann Arbor, Michigan 48106
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Saint Joseph Mercy Hospital
    Ann Arbor, Michigan 48106
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Brain and Central Nervous System Tumors
    Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Leukemia, Lymphoma
    Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
    C.S. Mott Children's Hospital at University of Michigan Medical Center
    Ann Arbor, Michigan 48109-0286
    Neuroblastoma
    Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC)
    University of Michigan Medical Center

    Trial Locations
    University of Michigan Medical Center
    University of Michigan Veterans Administration Hospital
    Head and Neck Cancer
    MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome
    Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
    University of Michigan Medical Center
    Ann Arbor, Michigan 48104-0914
    Head and Neck Squamous Cell Carcinoma
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    C S Mott Children's Hospital
    Ann Arbor, Michigan 48109
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    University of Michigan Comprehensive Cancer Center

    Trial Locations
    University of Michigan Comprehensive Cancer Center
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Lung Cancer
    Study of Oral MLN9708 in Adult Patients With Relapsed and/or Refractory Multiple Myeloma
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Relapsed and Refractory Multiple Myeloma
    Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia
    C S Mott Children's Hospital
    Ann Arbor, Michigan 48109
    Acute Undifferentiated Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent/Refractory Childhood Hodgkin Lymphoma, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific
    Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
    University of Michigan Comprehensive Cancer Center

    Trial Locations
    University of Michigan Comprehensive Cancer Center
    Saint Joseph Mercy Cancer Center
    Prostate Cancer
    Dinaciclib in Treating Patients With Stage IV Melanoma
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    University of Michigan University Hospital
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Mucosal Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer
    University of Michigan Health System
    Ann Arbor, Michigan
    Breast Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Lung Cancer
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy
    Saint Joseph Mercy Cancer Center
    Ann Arbor, Michigan 48106-0995
    Breast Cancer, Hot Flashes, Menopausal Symptoms, Unspecified Adult Solid Tumor, Protocol Specific
    Study of Blood Samples From Newborns With Down Syndrome
    C.S. Mott Children's Hospital at University of Michigan Medical Center
    Ann Arbor, Michigan 48109-0286
    Leukemia
    GE Healthcare VolumeRAD Lung Nodule Detection Study
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Pulmonary Nodule, Solitary, Multiple Pulmonary Nodules
    PRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate Biopsy
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Prostate Cancer
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Melanoma (Skin)
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Ann Arbor, Michigan 48106
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Chemotherapeutic Agent Toxicity, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Pain, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer
    START Rollover Study
    University of Michigan Medical Center
    Ann Arbor, Michigan 48104-0914
    Leukemia
    Combination Chemotherapy With or Without GDC-0449 in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Gastric Cancer, Stage III Gastric Cancer, Stage IV Gastric Cancer